RU2012106544A - METHOD FOR LASER EXECTION OF NOSE CAVITY POLYPES - Google Patents
METHOD FOR LASER EXECTION OF NOSE CAVITY POLYPES Download PDFInfo
- Publication number
- RU2012106544A RU2012106544A RU2012106544/14A RU2012106544A RU2012106544A RU 2012106544 A RU2012106544 A RU 2012106544A RU 2012106544/14 A RU2012106544/14 A RU 2012106544/14A RU 2012106544 A RU2012106544 A RU 2012106544A RU 2012106544 A RU2012106544 A RU 2012106544A
- Authority
- RU
- Russia
- Prior art keywords
- laser
- polypes
- exection
- nose cavity
- transection
- Prior art date
Links
- 208000037062 Polyps Diseases 0.000 claims abstract 4
- 206010002091 Anaesthesia Diseases 0.000 claims abstract 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims abstract 2
- 230000037005 anaesthesia Effects 0.000 claims abstract 2
- 239000000835 fiber Substances 0.000 claims abstract 2
- 229960004194 lidocaine Drugs 0.000 claims abstract 2
- 210000003928 nasal cavity Anatomy 0.000 claims abstract 2
- 230000005855 radiation Effects 0.000 claims abstract 2
- 239000004065 semiconductor Substances 0.000 claims abstract 2
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
Способ лазерного иссечения полипов полости носа, отличающийся тем, что после предварительной аппликационной анестезии 10%-ным раствором лидокаина контактным способом в непрерывном режиме с мощностью лазерного излучения 8,5 Вт и временем лазерного воздействия от 15 до 45 с разогретым дистальным торцом световода полупроводникового лазера выполняют перерезку ножки полипа.The method of laser excision of polyps of the nasal cavity, characterized in that after preliminary application anesthesia with a 10% lidocaine solution by contact method in a continuous mode with a laser radiation power of 8.5 W and a laser exposure time of 15 to 45 with a heated distal end of the semiconductor laser fiber, transection of the legs of the polyp.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012106544/14A RU2012106544A (en) | 2012-02-22 | 2012-02-22 | METHOD FOR LASER EXECTION OF NOSE CAVITY POLYPES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012106544/14A RU2012106544A (en) | 2012-02-22 | 2012-02-22 | METHOD FOR LASER EXECTION OF NOSE CAVITY POLYPES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012106544A true RU2012106544A (en) | 2013-08-27 |
Family
ID=49163571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012106544/14A RU2012106544A (en) | 2012-02-22 | 2012-02-22 | METHOD FOR LASER EXECTION OF NOSE CAVITY POLYPES |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2012106544A (en) |
-
2012
- 2012-02-22 RU RU2012106544/14A patent/RU2012106544A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123476T1 (en) | NUCLEAR TRANSPORT MODIFIERS AND THEIR USES | |
| CY1122730T1 (en) | 1,2,4-TRIAZOLES AS NUCLEAR TRANSPORT MODULATORS AND THEIR USES | |
| CY1121736T1 (en) | ARAMCHOL SALTS | |
| MX2014013315A (en) | Pharmaceutical nanoparticles showing improved mucosal transport. | |
| MX2021014709A (en) | Methods for increasing red blood cell levels and treating sickle-cell disease. | |
| CR20130377A (en) | DRUG METHODS AND PRODUCTS TO TREAT ALZHEIMER'S DISEASE | |
| EA201591426A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
| ECSP13012417A (en) | NAPHT-2-ILACETIC ACID DERIVATIVES TO TREAT AIDS | |
| EA201591432A1 (en) | COMPOUNDS AND THEIR APPLICATIONS FOR MODULATION OF HEMOGLOBIN | |
| MX366317B (en) | COMPOSITIONS AND METHODS TO TREAT CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES. | |
| AR093645A1 (en) | A STABILIZED FORMULATION OF PEMETREXED | |
| MX2015014589A (en) | Treatment of cancer with dihydropyrazino-pyrazines. | |
| MX2018007871A (en) | COMPOSITIONS FOR PERSONAL CARE. | |
| EA201792096A2 (en) | RAPPγ AGONISTS FOR TREATMENT OF MULTIDATED SCLEROSIS | |
| CL2015002171A1 (en) | Methods of treating iron difficulty with soluble ferric pyrophosphate. | |
| MX381102B (en) | BENRALIZUMAB FOR USE IN THE TREATMENT OF ASTHMA BY INCREASING FORCED EXPIRATORY VOLUME. | |
| CR20150553A (en) | COMPOSITIONS AND METHODS FOR LIVED ALFAVIRUS FORMULATIONS | |
| CY1120545T1 (en) | COMPOSITION FOR THE TREATMENT OF REDUCED SEXUAL DESCRIPTION | |
| MX376175B (en) | GRAPIPRANT COMPOSITIONS AND METHODS OF USING THE SAME. | |
| MX381429B (en) | Trichostatin A (TSA) for use in the treatment of cancer. | |
| RU2012106544A (en) | METHOD FOR LASER EXECTION OF NOSE CAVITY POLYPES | |
| RU2012106539A (en) | METHOD FOR TREATING NOSE POLYPOSIS | |
| BR112014002498A2 (en) | “Non-aqueous oral treatment composition” | |
| CU24433B1 (en) | A PROCESS TO PREPARE ISOXAFLUTOL IN THE PRESENCE OF A STRONG ACID | |
| MX383705B (en) | TUNGSTEN (VI) SALTS FOR USE IN THE TREATMENT OF INFERTILITY, TO PROMOTE FERTILITY AND NORMAL REPRODUCTION IN A NON-DIABETIC FEMALE MAMMAL, AS WELL AS TO ENHANCE THE EFFICACY OF ASSISTED REPRODUCTION TECHNIQUES. |